• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gastrointestinal and liver manifestations in patients with COVID-19.新型冠状病毒肺炎患者的胃肠道和肝脏表现。
J Chin Med Assoc. 2020 Jun;83(6):521-523. doi: 10.1097/JCMA.0000000000000319.
2
COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission.新型冠状病毒肺炎:胃肠道表现及潜在的粪-口传播
Gastroenterology. 2020 May;158(6):1518-1519. doi: 10.1053/j.gastro.2020.02.054. Epub 2020 Mar 3.
3
Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.新型冠状病毒肺炎的胃肠道和肝脏表现:全面综述。
World J Gastroenterol. 2020 May 21;26(19):2323-2332. doi: 10.3748/wjg.v26.i19.2323.
4
Gastrointestinal and liver manifestations of COVID-19.新型冠状病毒肺炎的胃肠道和肝脏表现
Saudi J Gastroenterol. 2020 Sep-Oct;26(5):226-232. doi: 10.4103/sjg.SJG_147_20.
5
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.综述文章:COVID-19 的胃肠道特征和粪便传播的可能性。
Aliment Pharmacol Ther. 2020 May;51(9):843-851. doi: 10.1111/apt.15731. Epub 2020 Mar 31.
6
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行:胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
7
COVID-19: gastrointestinal symptoms and potential sources of SARS-CoV-2 transmission.新型冠状病毒肺炎:胃肠道症状及严重急性呼吸综合征冠状病毒2的潜在传播源
Anaesthesiol Intensive Ther. 2020;52(2):171-172. doi: 10.5114/ait.2020.93867.
8
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.香港队列粪便样本中 SARS-CoV-2 感染的胃肠道表现及病毒载量:系统评价与荟萃分析
Gastroenterology. 2020 Jul;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065. Epub 2020 Apr 3.
9
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎患者胃肠道及肝脏受累的表现和预后:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678. doi: 10.1016/S2468-1253(20)30126-6. Epub 2020 May 12.
10
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.2019 年冠状病毒病患者的胃肠道症状和粪便病毒脱落的流行情况:系统评价和荟萃分析。
JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335.

引用本文的文献

1
COVID-19 - multisystem disease.新冠病毒病——多系统疾病。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):61-67. doi: 10.47162/RJME.66.1.05.
2
State of Knowledge About Thyroid Cancers in the Era of COVID-19-A Narrative Review.COVID-19时代甲状腺癌的知识现状——一篇综述
Biomedicines. 2024 Dec 13;12(12):2829. doi: 10.3390/biomedicines12122829.
3
Clinical Maternal and Neonatal Features in COVID-19 Infected Pregnancies in Tianjin, China.中国天津新冠病毒感染孕产妇的临床及新生儿特征
Int J Gen Med. 2024 Dec 11;17:6075-6087. doi: 10.2147/IJGM.S488808. eCollection 2024.
4
Cytokine Storm-Induced Thyroid Dysfunction in COVID-19: Insights into Pathogenesis and Therapeutic Approaches.细胞因子风暴导致的 COVID-19 甲状腺功能障碍:发病机制和治疗方法的见解。
Drug Des Devel Ther. 2024 Sep 20;18:4215-4240. doi: 10.2147/DDDT.S475005. eCollection 2024.
5
A Case of Spinal Cavernous Hemangioma with Rapidly Worsening Neurological Symptoms after COVID-19 Infection.1例新冠病毒感染后神经症状迅速恶化的脊髓海绵状血管瘤病例
Prog Rehabil Med. 2024 Aug 29;9:20240027. doi: 10.2490/prm.20240027. eCollection 2024.
6
Critical appraisal of how COVID-19 infection and imposed lockdowns have impacted gastroesophageal reflux: A review.新冠病毒感染和强制封锁对胃食管反流影响的批判性评价:综述。
Medicine (Baltimore). 2024 May 10;103(19):e38074. doi: 10.1097/MD.0000000000038074.
7
Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2.新型冠状病毒肺炎感染是一种多器官疾病吗?关注严重急性呼吸综合征冠状病毒2的肺外累及情况。
J Clin Med. 2024 Feb 28;13(5):1397. doi: 10.3390/jcm13051397.
8
Drug-induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID-19 in a patient under anastrozole therapy-A case report.在接受阿那曲唑治疗的患者中,轻度 COVID-19 后应用更新的 Roussel Uclaf 因果关系评估方法评估药物性肝损伤-1 例报告。
Cancer Rep (Hoboken). 2024 Apr;7(4):e2028. doi: 10.1002/cnr2.2028.
9
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?2023 年关于 COVID-19、可能的肝脏途径和酒精滥用,我们了解多少?
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
10
Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage.COVID-19 对线粒体和多器官损伤影响的转录组学和机器学习分析。
PLoS One. 2024 Jan 31;19(1):e0297664. doi: 10.1371/journal.pone.0297664. eCollection 2024.

本文引用的文献

1
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic.ESGE 和 ESGENA 关于胃肠内镜和 COVID-19 大流行的立场声明。
Endoscopy. 2020 Jun;52(6):483-490. doi: 10.1055/a-1155-6229. Epub 2020 Apr 17.
2
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.中国湖北有消化道症状的 COVID-19 患者的临床特征:一项描述性、横断面、多中心研究。
Am J Gastroenterol. 2020 May;115(5):766-773. doi: 10.14309/ajg.0000000000000620.
3
Considerations in performing endoscopy during the COVID-19 pandemic.2019冠状病毒病大流行期间进行内镜检查的注意事项。
Gastrointest Endosc. 2020 Jul;92(1):176-183. doi: 10.1016/j.gie.2020.03.3758. Epub 2020 Mar 27.
4
COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests.粪便病毒检测呈阳性而咽拭子和痰液病毒检测呈阴性的COVID-19疾病
Am J Gastroenterol. 2020 May;115(5):790. doi: 10.14309/ajg.0000000000000610.
5
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.2019冠状病毒病疫情期间粪便微生物群移植供体的筛查:国际专家小组提出的紧急更新建议
Lancet Gastroenterol Hepatol. 2020 May;5(5):430-432. doi: 10.1016/S2468-1253(20)30082-0. Epub 2020 Mar 17.
6
Coronavirus (COVID-19) outbreak: what the department of endoscopy should know.冠状病毒(COVID-19)爆发:内镜科应该了解什么。
Gastrointest Endosc. 2020 Jul;92(1):192-197. doi: 10.1016/j.gie.2020.03.019. Epub 2020 Mar 14.
7
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China.中国武汉2019年新型冠状病毒肺炎难治性病例的临床特征
Clin Infect Dis. 2021 Dec 6;73(11):e4208-e4213. doi: 10.1093/cid/ciaa270.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Implications of COVID-19 for patients with pre-existing digestive diseases.2019冠状病毒病对患有既往消化系统疾病患者的影响。
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427. doi: 10.1016/S2468-1253(20)30076-5. Epub 2020 Mar 11.
10
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.

新型冠状病毒肺炎患者的胃肠道和肝脏表现。

Gastrointestinal and liver manifestations in patients with COVID-19.

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.

出版信息

J Chin Med Assoc. 2020 Jun;83(6):521-523. doi: 10.1097/JCMA.0000000000000319.

DOI:10.1097/JCMA.0000000000000319
PMID:32243269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7176263/
Abstract

As the outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread over the world, the World Health Organization has declared the outbreak of COVID-19 an international public health emergency. Besides typical respiratory symptoms and signs of COVID-19, digestive symptoms and liver injury have been frequently reported during the course of the disease. In this review, we summarized the recent studies reporting of gastrointestinal and liver manifestations during the course of COVID-19. Digestive symptoms, including anorexia, nausea, vomiting, and diarrhea, are not uncommon in patients with COVID-19, and in some cases digestive symptoms may occur in the absence of any respiratory symptoms. Furthermore, SARS-CoV-2 could be detected in the stool of infected patients, implicating the possibility of fecal-oral transmission. Attention should also be paid to monitor liver function during the course of COVID-19, especially in patients with higher disease severity.

摘要

随着由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)的爆发在全球范围内迅速蔓延,世界卫生组织宣布 COVID-19 爆发为国际公共卫生紧急事件。除了 COVID-19 的典型呼吸道症状和体征外,在疾病过程中还经常报告有消化系统症状和肝损伤。在这篇综述中,我们总结了最近报道的 COVID-19 过程中胃肠道和肝脏表现的研究。在 COVID-19 患者中,消化系统症状(包括厌食、恶心、呕吐和腹泻)并不少见,在某些情况下,即使没有任何呼吸道症状,也可能会出现消化系统症状。此外,在感染患者的粪便中可检测到 SARS-CoV-2,这意味着存在粪-口传播的可能性。在 COVID-19 过程中还应注意监测肝功能,尤其是在疾病严重程度较高的患者中。